Cargando…
OL-043 Mechanism and therapeutic efficacy of peroxisome proliferator activated receptor agonist for virus-associated hemophagocytic syndrome
Autores principales: | Chen, Y.L., Hsieh, W.C., Lan, B.S., Su, I.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Infectious Diseases. Published by Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129163/ http://dx.doi.org/10.1016/S1201-9712(09)60140-5 |
Ejemplares similares
-
Control of Virus-\associated Hemophagocytic Syndrome by Peroxisome Proliferator Activated Receptor Agonists in a Rabbit Model
por: Hsieh, W.C., et al.
Publicado: (2008) -
OL-045 Clinical significance of beta-herpesvirus infections in HIV/AIDS and chronic fatigue syndrome patients in Latvia
por: Krumina, A., et al.
Publicado: (2008) -
AB81. Therapeutic potential of adipose-derived stem cells based micro-tissues in a rat model of post-prostatectomy erectile dysfunction
por: Xu, Yongde, et al.
Publicado: (2014) -
Neurologic Wilson disease: case series on a diagnostic and therapeutic emergency
por: Porlas Jr, Romeo V., et al.
Publicado: (2018) -
First case report of tDCS efficacy in severe chemsex addiction
por: Malandain, Léo, et al.
Publicado: (2020)